KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Organon (OGN) Leases (2020 - 2025)

Organon has reported Leases over the past 6 years, most recently at $155.0 million for Q4 2025.

  • Quarterly results put Leases at $155.0 million for Q4 2025, down 1.27% from a year ago — trailing twelve months through Dec 2025 was $155.0 million (down 1.27% YoY), and the annual figure for FY2025 was $155.0 million, down 1.27%.
  • Leases for Q4 2025 was $155.0 million at Organon, down from $157.0 million in the prior quarter.
  • Over the last five years, Leases for OGN hit a ceiling of $293.0 million in Q2 2021 and a floor of $155.0 million in Q4 2025.
  • Median Leases over the past 5 years was $215.0 million (2022), compared with a mean of $215.9 million.
  • Biggest five-year swings in Leases: surged 641.94% in 2021 and later dropped 19.53% in 2023.
  • Organon's Leases stood at $230.0 million in 2021, then dropped by 6.52% to $215.0 million in 2022, then dropped by 19.53% to $173.0 million in 2023, then dropped by 9.25% to $157.0 million in 2024, then decreased by 1.27% to $155.0 million in 2025.
  • The last three reported values for Leases were $155.0 million (Q4 2025), $157.0 million (Q4 2024), and $173.0 million (Q4 2023) per Business Quant data.